Clinical approach to penicillin-allergic patients: a survey

被引:81
作者
Solensky, R [1 ]
Earl, HS [1 ]
Gruchalla, RS [1 ]
机构
[1] Univ Texas, SW Med Ctr, Dept Internal Med, Div Allergy & Immunol, Dallas, TX 75235 USA
关键词
D O I
10.1016/S1081-1206(10)62782-2
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: Approximately 10% of individuals report a history of penicillin allergy. Objective: We chose to survey various physician groups to determine how they would manage penicillin-allergic patients who present with an infectious process for which penicillin is the drag of choice. Methods: In situations where penicillin was the drug of choice, physicians were asked to choose the type of antibiotic treatment for patients who presented with diseases of varying severity and who had either vague or convincing penicillin-allergic histories. Results: A total of 601 surveys were mailed and 93 (16%) were returned. For those patients who present with a vague history of penicillin allergy, 58% and 59% of the physicians surveyed stated that they would choose cephalosporins for individuals with mild and moderate diseases, respectively. In contrast, in the vague penicillin history/severe disease scenario, physicians were split between choosing cephalosporins (42% of responders) and vancomycin (40% of responders). For those patients who present with a convincing history of penicillin allergy, 55% of the physicians chose erythromycin for individuals with mild disease; 44% chose quinolones for individuals with moderate disease, and 63% chose vancomycin for individuals with severe disease. In each of the three disease severities, physicians were significantly more likely to choose cephalosporins for patients with a vague history of penicillin allergy than for patients with a convincing history teach P<10(-5)). Conclusion: The choice of antibiotics is influenced both by the type of penicillin allergic history and by the severity of the disease process to be treated. To decrease the use of broad-spectrum antibiotics in patients labeled "penicillin-allergic'', an effort should be made to identify, by skin testing, those patients who lack penicillin-specific IgE antibodies.
引用
收藏
页码:329 / 333
页数:5
相关论文
共 23 条
[1]   ROUTINE USE OF PENICILLIN SKIN TESTING ON AN INPATIENT SERVICE [J].
ADKINSON, NF ;
THOMPSON, WL ;
MADDREY, WC ;
LICHTENSTEIN, LM .
NEW ENGLAND JOURNAL OF MEDICINE, 1971, 285 (01) :22-+
[2]  
ANNE S, 1995, ANN ALLERG ASTHMA IM, V74, P167
[3]  
[Anonymous], 1995, MMWR Recomm Rep, V44, P1
[4]   CROSS-REACTIVITY BETWEEN PENICILLINS AND CEPHALOSPORINS - CLINICAL AND IMMUNOLOGICAL STUDIES [J].
BLANCA, M ;
FERNANDEZ, J ;
MIRANDA, A ;
TERRADOS, S ;
TORRES, MJ ;
VEGA, JM ;
AVILA, MJ ;
PEREZ, E ;
GARCIA, JJ ;
SUAU, R .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1989, 83 (02) :381-385
[5]   Emerging antibiotic resistance [J].
Bonafede, M ;
Rice, LB .
JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1997, 130 (06) :558-566
[6]   Vancomycin-resistant Enterococcus - Detection, epidemiology, and control measures [J].
Boyce, JM .
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 1997, 11 (02) :367-&
[7]   PENICILLIN ALLERGY - ANTI-PENICILLIN IGE ANTIBODIES AND IMMEDIATE HYPERSENSITIVITY SKIN REACTIONS EMPLOYING MAJOR AND MINOR DETERMINANTS OF PENICILLIN [J].
CHANDRA, RK ;
JOGLEKAR, SA ;
TOMAS, E .
ARCHIVES OF DISEASE IN CHILDHOOD, 1980, 55 (11) :857-860
[8]   CLINICAL-EXPERIENCE WITH PENICILLIN SKIN TESTING IN A LARGE INNER-CITY STD CLINIC [J].
GADDE, J ;
SPENCE, M ;
WHEELER, B ;
ADKINSON, NF .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 270 (20) :2456-2463
[9]   EVALUATION OF PENICILLIN HYPERSENSITIVITY - VALUE OF CLINICAL HISTORY AND SKIN TESTING WITH PENICILLOYL-POLYLYSINE AND PENICILLIN-G [J].
GREEN, GR ;
ROSENBLUM, AH ;
SWEET, LC .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1977, 60 (06) :339-345
[10]   Skin testing with penicilloate and penilloate prepared by an improved method: Amoxicillin oral challenge in patients with negative skin test responses to penicillin reagents [J].
Macy, E ;
Richter, PK ;
Falkoff, R ;
Zeiger, R .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1997, 100 (05) :586-591